Saturday, September 23, 2023
Saturday, September 23, 2023

Vivalink Releases Biometrics Data Platform 2.0, Increasing Remote Patient Monitoring Patient Adherence

Vivalink, a leading provider of digital healthcare solutions, has released an updated version of its Biometrics Data Platform with new features aimed at increasing patient adherence in Remote Patient Monitoring (RPM).

Vivalink’s Biometrics Data Platform accelerates the implementation and time-to-market of remote patient monitoring for healthcare and clinical trials by combining a turn-key end-to-end solution consisting of a suite of wearable sensors, edge-to-cloud integration, and advanced data  management and analytics both in real-time and retrospectively. The software platform is designed for flexible interoperability with mobile and web enabled clinical applications, electronic health record (EHR) systems and clinical trial management systems (CTMS).

While the adoption of RPM has accelerated with the pandemic and is expected to grow exponentially, patient adherence remains a top challenge. In a Decentralized Clinical Trial (DCT) survey by Vivalink, 69 percent of respondents indicated ‘patient adherence’ as the top concern.

To address this concern, the new Biometrics Data Platform updates include:

  • Data Integrity Assurance – notification of interruptions in data capture
  • New Adhesives Options – designed for sensitive skin and facilitates extended wear times
  • Sensor Status Indicators – detects when sensors are not connected or have become disconnected
  • Central Operational Console – systems management view of distributed patient sensors and data capture status across multiple locations to ensure proper adherence
  • Data Management Portal – A multi-functional web portal for patient/participant management, vital data visualization, analysis, and notifications based on advanced algorithms

Vivalink takes a “patient centric” approach to its RPM solution, which includes making its devices as easy to use and comfortable as possible for the patient. For example, its medical grade multi-vital cardiac patch is among the world’s smallest and lightest, weighing just 7.5 grams, increasing comfort while reducing disruption to daily routines.

“As a technology solution provider, we strive for the most advanced and effective solutions for remote patient monitoring,” said Jiang Li, CEO of Vivalink. “Patient adherence is a major bottleneck for the wider adoption of RPM. Today’s release of these features focusing on improving patient adherence shows our firm commitment to the patient-centric approach of our solution.

”More than 150 digital healthcare solution partners and commercial customers in 41 countries are delivering a wide range of medical applications using Vivalink’s Biometrics Data Platform. Vivalink’s solution is the basis of clinical research studies at leading institutions, including a 3,000 patient atrial fibrillation study at UCSF and a study of the effects of stress and teenage depression at Stanford University. Most recently, the platform has been adopted by health technology companies developing AI solutions, algorithm development and validation. The platform meets high levels of global compliance, including HIPAA, GDPR, FDA 21 CFR Part 11, ISO 13485, IEC 62304, ISO 14971, ISO 10993, and ISO 27001.

For more information, visit

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Lipogems® Announces 140 Independent Peer Reviewed Publications with 5 Years of Follow up in Orthopaedics

Giorgio Ninzoli, President of Lipogems International. "The gold standard for evidence is 1 year follow up and we are excited to report 5 years follow up with positive results after a single injection of MicroFat."

Stryker’s Triathlon Tritanium Baseplate Marks a Decade of Positive Patient Impact

Marking its 10th anniversary, the Triathlon Tritanium baseplate is designed with Stryker Orthopaedic Modeling and Analytics (SOMA) and enabled by Stryker's proprietary additive manufacturing technology.

Medtronic Diabetes Announces CE Mark for New Simplera™ CGM with Disposable All-in-one Design

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience

Study Outcomes Could Provide Insights Into New Targeted Treatments to Manage this Challenging Disease

The study aims to determine if immediate biological preservation of patient-derived chordoma tumor tissue, collected intraoperatively and implanted for serial sampling in translational research, will provide new insights into the biological weakness of the disease and contribute to developing improved treatment therapies reports NICO.

Henkel Joins with MedTech Europe to Drive Innovation In the Medical Technology Industry

Henkel has a long history of supporting the medical technology industry with its advanced adhesive and surface solutions. Through this, Henkel and MedTech Europe will collaborate on various initiatives such as supporting research and development projects, driving thought leadership and engaging in industry forums.

By using this website you agree to accept Medical Device News Magazine Privacy Policy